IGLV3-25
Immunoglobulin lambda variable 3-25
Also known as: LV325_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01717
- Gene
- IGLV3-25
- Ensembl
- ENSG00000211659
- Chromosome
- 22
- Canonical length
- 112 aa
- Protein class
- Immunoglobulin genes, Predicted secreted proteins
- Secretome location
- Immunoglobulin genes
OverviewNCBI Gene
Predicted to enable antigen binding activity. Predicted to be involved in immune response. Located in blood microparticle. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
112 residues, UniProt reviewed canonical sequence.
>P01717|IGLV3-25
1 MAWIPLLLPL LTLCTGSEAS YELTQPPSVS VSPGQTARIT CSGDALPKQY AYWYQQKPGQ
61 APVLVIYKDS ERPSGIPERF SGSSSGTTVT LTISGVQAED EADYYCQSAD SSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGLV3-25 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 2,275 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 2,275 nTPM
- lymph node: 960 nTPM
- stomach: 955 nTPM
- lung: 822 nTPM
- colon: 791 nTPM
- urinary bladder: 732 nTPM
Single-cell type
- plasma cells: 24 nCPM
- gastric chief cells: 12 nCPM
- parietal cells: 5.3 nCPM
- mucous neck cells: 2.4 nCPM
- foveolar cells: 2.3 nCPM
- b-cells: 1.1 nCPM
Immune cell
- naive B-cell: 799 nTPM
- memory B-cell: 548 nTPM
- total PBMC: 77 nTPM
- neutrophil: 15 nTPM
- basophil: 0.8 nTPM
- gdT-cell: 0.7 nTPM
Brain region
- medulla oblongata: 3.4 nTPM
- choroid plexus: 2.4 nTPM
- cerebral cortex: 1.1 nTPM
- pons: 0.9 nTPM
- white matter: 0.8 nTPM
- thalamus: 0.7 nTPM
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGLV3-25 as an antibody target. Whether an autoantibody or antibody against IGLV3-25 could matter depends on whether native IGLV3-25 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGLV3-25 is annotated at the cell surface, where native IGLV3-25 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IGLV3-25 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...